<--- Back to Details
First PageDocument Content
Pharmacology / Health / Clinical research / Drug safety / Supplementary protection certificate / European Medicines Agency / Qualified Person for Pharmacovigilance / Drug Master File / Marketing authorization / Pharmaceutical sciences / Pharmaceuticals policy / Pharmaceutical industry
Date: 2009-03-19 06:42:41
Pharmacology
Health
Clinical research
Drug safety
Supplementary protection certificate
European Medicines Agency
Qualified Person for Pharmacovigilance
Drug Master File
Marketing authorization
Pharmaceutical sciences
Pharmaceuticals policy
Pharmaceutical industry

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL

Add to Reading List

Source URL: www.lakemedelsverket.se

Download Document from Source Website

File Size: 348,00 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document